n) Provisions, Contingent Liabilities and
Contingent Assets

i. A contingent liability is a possible obligation
that arises from past events whose
existence will be confirmed by the occurrence
or non-occurrence of one or more uncertain
future events beyond the control of the

Company or a present obligation that is not
recognized because it is not probable that
an outflow of resources will be required to
settle the obligation. A contingent liability also
arises in extremely rare cases where there is
a liability that cannot be recognized because
it cannot be measured reliably. The Company
does not recognize a contingent liability
but discloses its existence in the financial
statements. Contingent liabilities, if material,
are disclosed by way of notes and contingent
assets, if any, are disclosed in the notes to
financial statements.

Contingent liabilities, which according to the
management are not expected to materialize
are not recognized in the financial statements
are disclosed in the notes to the accounts.
Contingent assets are neither recognized nor
disclosed in financial statements.

ii. A provision is recognized, when Company has
a present obligation (legal or constructive)
as a result of past events and it is probable
that an outflow of resources embodying
economic benefits will be required to settle
the obligation, in respect of which a reliable
estimate can be made for the amount of
obligation. The expense relating to the
provision is presented in the profit and loss
net of any reimbursement. If the effect of the
time value of money is material, provisions are
discounted using a current pretax rate that
reflects, when appropriate, the risks.

o) Segment Reporting

The company is mainly into the business of
rendering hospital services. Other services like sale
of medicine, canteen foods etc are ancillary to the
main services and thus the only business segment,
in terms of IND AS 108 and therefore no separate
reporting under ‘Segment Reporting' is required

p) Cash flows

Cash flows are reported using the indirect method,
where by profit before tax is adjusted for the effects
of transactions of a non-cash nature, any deferrals
or accruals of past or future operating cash receipts
or payments and item of income or expenses
associated with investing or financing cash flows.
The Cash flows from operating, investing and
financing activities of the company are segregated

q) Impairment of Assets

The Company assesses, at each reporting date,
whether there is an indication that an asset may

be impaired. If any indication exists, or when
annual impairment testing for an asset is required,
the Company estimates the asset's recoverable
amount. An asset's recoverable amount is the
higher of an asset's or cash-generating unit's (CGU)
fair value less costs of disposal and its value in use.
Recoverable amount is determined for an individual
asset, unless the asset does not generate cash
inflows that are largely independent of those from
other assets or groups of assets. When the carrying
amount of an asset or CGU exceeds its recoverable
amount, the asset is considered impaired and is
written down to its recoverable amount.

In assessing value in use, the estimated future cash
flows are discounted to their present value using a
pre-tax discount rate that reflects current market
assessments of the time value of money and the
risks specific to the asset. In determining fair value
less costs of disposal, recent market transactions are
taken into account. If no such transactions can be
identified, an appropriate valuation model is used.
These calculations are corroborated by valuation
multiples, quoted share prices for publicly traded
companies or other available fair value indicators.

Impairment losses of continuing operations,
including impairment on inventories, are
recognised in the statement of profit and loss,
except for properties previously revalued with the
revaluation surplus taken to Other Comprehensive
Income (OCI). For such properties, the impairment
is recognised in OCI up to the amount of any
previous revaluation surplus.

For assets other than goodwill, an assessment is
made at each reporting date to determine whether
there is an indication that previously recognised
impairment losses no longer exist or have
decreased. If such indication exists, the Company
estimates the asset's or CGU's recoverable amount.
A previously recognised impairment loss is reversed
only if there has been a change in the assumptions
used to determine the asset's recoverable amount
since the last impairment loss was recognised. The
reversal is limited so that the carrying amount of
the asset does not exceed its recoverable amount,
nor exceed the carrying amount that would have
been determined, net of depreciation, had no
impairment loss been recognised for the asset
in prior years. Such reversal is recognised in the
statement of profit or loss unless the asset is carried
at a revalued amount, in which case, the reversal is
treated as a revaluation increase.

Goodwill is tested for impairment as at each
Balance Sheet date and when circumstances
indicate that the carrying value may be impaired.

Impairment is determined for goodwill by
assessing the recoverable amount of each CGU
(or group of CGUs) to which the goodwill relates.
When the recoverable amount of the CGU is less
than its carrying amount, an impairment loss is
recognised. Impairment losses relating to goodwill
cannot be reversed in future periods.

Intangible assets with indefinite useful lives are
tested for impairment annually as at each Balance
sheet date at the CGU level, as appropriate, and
when circumstances indicate that the carrying
value may be impaired.

When an impairment loss subsequently reverses,
the carrying amount of the asset (or a cash¬
generating unit) is increased to the revised estimate
of its recoverable amount, but so that the increased
carrying amount does not exceed the carrying
amount that would have been determined had no
impairment loss been recognised for the asset (or
cash-generating unit) in prior years. A reversal of
an impairment loss is recognised immediately in
profit or Loss.

r) Current and non-current assets and liabilities

All financial assets and liabilities maturing with-in
the time period of operating cycle which at present
is 1 year are considered current assets or liabilities.
All assets and liabilities, not being current are
considered noncurrent assets or liabilities.

s) Expenditure during construction period:

Assets in the course of construction are capitalized
in the assets and treated as capital work in progress
and upon commissioning of project the assets
are capitalised and transferred to appropriate
category of PPE. At the point when an asset is
operating at management's intended use, the
cost of construction is transferred to appropriate
category of PPE.

t) Initial public offer/ Qualified Institutional
Placement related transaction costs

The expenses pertaining to Initial Public Offer (‘IPO')
/ Qualified Institutional Placement (QIP) includes
expenses pertaining to issue of equity shares, offer
for sale by selling shareholders and listing of equity
shares and has been accounted for as follows:

a. Incremental costs that are directly attributable
to issuing new shares were deferred and on
consummation of IPO, the same have been
deducted from equity;

b. Incremental costs that are not directly
attributable to issuing new shares or offer
for sale by selling shareholders, has been
recorded as an expense in the statement of
profit and loss as and when incurred; and

c. Costs that relate to issue of equity shares and
offer for sale by selling shareholders has been
allocated on a rational and consistent basis as
per the agreed terms.

u) All figures reported are in Rupees Millions unless
otherwise stated.

Trade receivables are unsecured and are derived from revenue earned from providing medical, healtchare and
other ancillary services. No interest is charged on the outstanding balance, regardless of the age of the balance. The
company applies Expected Credit Loss (ECL) model for measurement and recognition of impairement loss towards
expected risk of delays and default in collection.

The company has used a practical expedient by computing the expected credit loss allowance based on recovery
pattern of receivables in the past. Management makes specific provision in cases where there are known specific
risks of customer default in making repayments. The provision matrix takes into account historical credit loss
experience and adjusted for forward-looking information.

Note 34(i) : Fair Value Measurement (Contd..)

(i) Fair Value Hierarchy

The financial instruments are categorised into three levels based on the inputs used to arrive at fair value
measurements as described below:

Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 2: Inputs other than the quoted prices included within Level 1 that are observable for the asset or liability,
either directly or indirectly; and

Level 3: Inputs based on unobservable market data

Valuation Methodology

All financial instruments are initially recognised and subsequently re-measured at fair value as described below:
a) The fair value of investment in Mutual Funds is measured at NAV.

(ii) Valuation techniques used to determine Fair value

The Company maintains policies and procedures to value financial assets or financial liabilities using the best
and most relevant data available. The fair values of the financial assets and liabilities are included at the amount
that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market
participants at the measurement date.

The Company's principal financial liabilities other than derivatives comprise loans and borrowings trade and other
payables. The main purpose of these financial liabilities is to finance the Company's operations. The Company's
principal financial assets include Lease Liabilities, loans trade and other receivables and cash and cash equivalents
that are derived directly from its operations.

The Company's financial risk management is an integral part of how to plan and execute its business strategies. The
Company is exposed to market risk credit risk and liquidity risk. The company's focus is to foresee the unpredictability
of financial markets and seek to minimize potential adverse effects on its financial performance.

The Company's principal financial liabilities comprise borrowings trade and other payables. The main purpose of
these financial liabilities is to manage finances for the Company's operations. The Company principal financial asset
includes loan trade and other receivables and cash and short-term deposits that arise directly from its operations.

The Company's activities are exposed to market risk, credit risk and liquidity risk.

I. Market risk

Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of
changes in market prices. Market prices comprise three types of risk: currency rate risk interest rate risk and
other price risks such as equity price risk and commodity price risk. Financial instruments affected by market
risk include loans and borrowings deposits investments and derivative financial instruments.

The sensitivity of the relevant profit or loss item is the effect of the assumed changes in respective market risks.

(a) Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate
because of changes in market interest rates. In order to optimize the Company's position with regard
to interest income and interest expenses and to manage the interest rate risk treasury performs a
comprehensive corporate interest rate risk management by balancing the proportion of the fixed rate and
floating rate financial instruments in its total portfolio.

(ii) As at the end of reporting period the company had the following variable rate borrowings and interest
rate swap contracts outstanding: Nil

(iii) Sensitivity

Profit/loss is sensitive to higher/lower interest expense from borrowings as a result of changes in
interest rates: N/A

(b) Foreign currency risk

Foreign currency risk is the risk that the fair value or future cash flows of an exposure will fluctuate because
of changes in foreign exchange rates. The Company has no foreign currency loans in current year end and
previous year . Therefore no sensitivity is provided.

(c) Price Risk

The company's exposure to equity securities/ mutual funds price risk arises from the investments held by
the company and classified in the balance sheet at fair value through profit and loss. As at 31st March, 2025
the company has quoted investment in SBI Arbitrage opportunities Fund-Direct.

II. Credit risk

Credit risk refers to the risk that a counterparty will default on its contractual obligations resulting in financial
loss to the Company. The company has adopted a policy of only dealing with creditworthy counterparties and
obtaining sufficient collateral where appropriate as a means of mitigating the risk of financial loss from defaults.
The company's credit risk exposure towards its counterparties are continuously monitored . Credit exposure of
any party is controlled reviewed and approved by the appointed company official in this regard.

III. Liquidity Risk

Liquidity risk is defined as the risk that company will not be able to settle or meet its obligation on time or
at a reasonable price. The Company's objective is to at all times maintain optimum levels of liquidity to meet
its cash and collateral requirements. The Company's management is responsible for liquidity funding as well
as settlement management. In addition processes and policies related to such risk are overseen by senior
management. Management monitors the company's net liquidity position through rolling forecast on the basis
of expected cash flows.

The Company manages its capital to ensure that the company will be able to continue as going concerns while
maximising the return to stakeholders through the optimization of the debt and equity balance.

The Company's risk management committee reviews the capital structure of the Company on a semi-annual
basis. As part of this review, the committee considers the cost of capital and the risks associated with each class
of capital. The Company monitors capital on the basis of following gearing ratio, which is net debt divided by
total capital plus debt.

~ Nature of CSR Activities

Amount during the year ended 31st March, 2025 has been paid to charitable society which works for health care
of poor people.

The computation of CSR dues is as per the provision of Section 135 of The Companies Act, 2013. Further, the
company has paid excess amount of H 10.00 million for CSR contribution and the same is being carried forward
as per provisions of earlier mentioned section of The Companies Act, 2013.

Note 39: Employee benefit plans

The employee benefit schemes are as under:

Defined Retirement Plans

(1) Provident Fund

The benefit of Provident Fund is extended to all such eligible employees, as is defined under the relevant
regulations under the applicable the provisions of Provident Fund Act and the Rules and ESIC. Amount debited
to Statement of Profit and Loss including Administrative and Employees Deposit Linked Insurance charge and
ESIC amounts to H 10.32 millions during the period (FY- 23-24 H 4.72 millions).

(2) Gratuity

Gratuity - The liability for Gratuity is provided on the basis of Actuarial Valuation made at the end of each
financial year. The Actuarial Valuation is made on Projected Unit Credit method as per Ind AS 19.

The company has got valuation done for corporate guarantee from approved merchant banker. As per the
report no liability accrues on the company for the corporate guarantee provided by the company for the loans
granted to its subsidiary.

b) The income tax department conducted searches under section 132 of the Income tax act at the premises
belonging to the holding company, subsidiary companies and the key managerial persons of the Company.
The Company provided the necessary information and data, as required by the Income Tax department and
provided the fullest co-operation. The Income Tax Department took data back-ups and other information.
The business operations of the Company continued without any disruptions and the department has so far
not raised any income tax demand. The Company shall continue to provide the required co-operation and
information to the department and is confident that this search will not cause any significant tax liability
on the Company.

Also, the department had ordered for provisional attachment under Section 281B of the IT Act, of (i) 20,714,727
unquoted equity shares of face value H 10 each of AKS; (ii) 5,622,950 unquoted equity shares of face value of 10
of Sanskar Medica India Limited; (iii) 4,010,000 unquoted equity shares of face value of 10 of Ramraja; and (iv)
45,000,980 unquoted equity shares of face value of 10 of Pristine Infracon Private Limited, held by our Company
and group properties located at (a) Plot No. NH 32, Sector Omega I, Greater Noida, Uttar Pradesh, India; (b)
NH-01, Sector 110, Noida, Gautam Budh Nagar, Uttar Pradesh, India; and prohibited the holder/ owner from
transferring/ parting with such property from the date of such respective orders in order to protect its interest.

c) Other contingent liabilities

i. A case has been filed within the jurisdiction of Gautam Budh Nagar, Uttar Pradesh against a director
and the doctors of the company for medical negligence. The opponent party has not specified any
compensation for the said alleged medical negligence.

ii. First Information Report dt. November 19, 2022 has been filed against the doctors and the management of
the Company for medical negligence. The quantum in the case instant is not yet ascertained

Note:- For all the contingent liabilities mentioned hereinabove, the Company believes that it is not liable to pay
any amount and has not provided any sum for these liabilities in its books of accounts. The Company is dealing
with these cases at appropriate legal forum

d) Commitments

i) The company had been allotted Plot No- NH-31 in Sector Omega-1, Greater Noida by Greater Noida
Industrial Development Authority (GNIDA) on 18th March 2023. The total consideration to be paid was
H 95.72 million (including payment towards lease charges). The company has already deposited H 95.72
million by 31st March, 2025 (including payment towards lease charges). The land is yet to be registered in
the name of the company.

ii) The company has capital commitments of H 122.39 million (net of advance paid) for purchase of
hospital equipment.

iii) The Company has imported Capital Goods under Export Promotion Capital Goods Scheme [EPCG], where-
under the Company is required to fulfil export obligation/deemed exports amounting to H 94.62 Mn
[Previous Year H 90.58 Million]. The Liability amounting to H 94.62 Mn [Previous Year 90.58 Mn Million] on

41. Contingent liabilities and Commitments (Contd..)

account of custom duty may arise along with interest @15% p.a., in the event of non-fulfilment of export
obligation. The Company has completed export obligation amounting to H 36.03 Mn (Previous Year 7.46
Mn) upto end of this financial year and submitted the relevant documents with Director General Foreign
Trade for seeking fulfilment of export obligation certificate

42. There is no impairment loss on fixed assets on the basis of review carried out by the management in accordance
with IND AS 36.

43. Balances of certain trade receivables, loans & advances, advances received from customers and trade payables
are subject to confirmation, if any. The management does not expect any material difference affecting the financial
statements on such adjustments.

46. Details related to borrowings secured against current assets:

The company has given current assets (trade receivables and inventories) as security for a working capital loan or H
500 million (fund and non-fund-based limits) obtained from Kotak Bank, which is yet to be availed. This sanction is
availed from Q2 of FY 2024-25. There was working capital loan from State Bank of India till Q1 of the FY 2023-24. The
Company submitted the required information with the bank and the required reconciliation is presented below:

47. Other Statutory Information

a) The Company does not have any Benami property, where any proceeding has been initiated or pending against
the Company for holding any Benami property.

b) The Company does not have any transactions with struck off companies.

c) The Company does not have any charges or satisfaction which is yet to be registered with Registrar of Companies
beyond the statutory period.

d) The Company has not traded or invested in Crypto currency or Virtual Currency during the period ending 31st
March 2025 and year ended 31st March, 2024.

e) The Company has not advanced or loaned or invested funds to any other person(s) or entity(ies), including
foreign entities (Intermediaries) with the understanding that the Intermediary shall:

i. directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or
on behalf of the company (Ultimate Beneficiaries); or

ii. provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries

f) The Company has not received any fund from any person(s) or entity(ies), including foreign entities (Funding
Party) with the understanding (whether recorded in writing or otherwise) that the Company shall:

i. directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or
on behalf of the Funding Party (Ultimate Beneficiaries); or

ii. provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries,

50. During the current financial year FY 2024-25, the Company raised further funds from Qualified Institutional
buyers (QIB) in qualified institutional placements. In QIP Fresh issue of 105,04,124 Equity Shares was made at a price
of H 595/- for an amount aggregating to H 6249.95 million by our Company (“Fresh Issue").

51. The Company had participated in an e-auction under the Securitisation and Reconstruction of Financial Assets
and Enforcement of Security Interest Act of 2002 (“SARFAESI Act") conducted by Union Bank of India on October 29,
2024, for purchase of (i) a leasehold land building, which is a hospital located at Plot No. 4C, Institutional Area, Model
Town - III, Shahid Ram Prasad Bismil Marg Delhi 110009, India, admeasuring to 8,000 square meters, comprising of
four-story hospital building with two basement floors; and (ii) hypothecated plant and machinery present inside the
hospital premises as movable and immovable item, under pari passu charge with Union Bank of India (collectively
“Scheduled Property"). Subsequently, the sale confirmation letter dated October 30, 2024 was issued by Union Bank
of India to our Company.

Accordingly, the Company had paid the entire Sale Consideration in permitted trenches. The final letter was received
from Union Bank of India on 15.03.2025 and the registration of property has been done on 28th March 2025. The
company hopes to commence commercial operations soon.

52. The Company had entered into a strategic collaboration agreement to acquire 60% equity shareholding for
H912.00 million (“ Purchase consideration") in MGS Infotech Research and Solutions Private Limited (“MGS"), on
a going concern basis, along with transfer of all rights and interest by the existing shareholders towards assets
(including fixed assets and current assets) and liabilities in a hospital in Faridabad, Haryana, with an enterprise value
of H1,520.00 million having capacity of over 400 beds. The company has entered into the share purchase agreement
and has acquired 60% in MGS. Accordingly, MGS has become a subsidiary of the company. The company hopes to
commence commercial operations soon.

53. The previous year's figures have been regrouped /reclassified to confirm with the current year requirements.

54. These Financial Statements were approved by Board in its Meeting held on 26/05/2025 at Noida.

As per our report of even date

For R.Nagpal Associates For and on behalf of the Board of Directors

Chartered Accountants Yatharth Hospital & Trauma Care Services Limited

Firm Registration No.002626N

(Rohit Mehra) Dr. Ajay Kumar Tyagi Yatharth Tyagi Mr. Amit Kumar Singh

Partner Chairman & Director CEO

M.No.093910 Whole-Time Director DIN: 09322889 PAN: BFZPS6168A

Place: Noida DIN:01792886

Dated: 26/05/2025

Ritesh Mishra Pankaj Prabhakar

Co. Secretary & Compliance Officer CFO

M. No 51166 AGFPP2937A